IBO vs STZ · rev $10.0K vs P/E 14, rev $9.14B
Impact BioMedical, Inc. (IBO) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
IBO currently screens at market cap $7.6M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the IBO and STZ stock pages for the full models.
Not investment advice.